Abstract: The present invention relates to a selected amide of ?-hydroxybutyric acid, a process of manufacture and uses thereof. The invention also includes a pharmaceutical composition comprising an effective amount of the selected compound of the invention for use in preventing or treating drug addiction, especially alcohol misuse or dependency.
Abstract: Crystalline polymorphic forms of a compound of formula N-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide are described. The two polymorphic forms, named polymorphic Form A and polymorphic Form B, can be used in the treatment of drug addiction and alcoholism and have very good stability. Methods for preparing the polymorphic forms are also described.
Abstract: Crystalline polymorphic forms of a compound of formula N-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide are described. The two polymorphic forms, named polymorphic Form A and polymorphic Form B, can be used in the treatment of drug addiction and alcoholism and have very good stability. Methods for preparing the polymorphic forms are also described.
Abstract: The present invention relates to the use of &ggr;-hydroxybutyric acid amides in the treatment of drug addiction and alcoholism, more particularly in reducing chronic alcoholics' desire for and habit of consuming alcoholic drinks and in the treatment of the syndrome of abstinence from alcohol.
Abstract: Automatic equipment (1) to wash, disinfect, dry and stimulate the dairy animals'teats and in particular of dairy cows, comprising a washing part (3) supplied with an opening (5) to introduce the teat to be washed, containing two counterrotating brushes at horizontal axis (7a) and (7b) and spray devices (29) for the detergent and sanitizing solution, characterized in that it has a cup-like brush (8), placed below the two counterrotating brushes (7a) and (7b), with a rotation axis perfectly coincident with the entry of the teat in the equipment. To allow the two counterrotating brushes (7a) and (7b)to adjust to the teat conicity which is more accentuated near the udder, they are supplied as well with automatic devices for lateral movement of the rotation axis.
Abstract: Controlled release pharmaceutical compositions administrable by oral route, containing as the active principle at least one salt of the gamma hydroxy butyric acid with a pharmaceutically acceptable cation, for the treatment of alcoholism, opium like substances addiction, heroin addiction, food and nicotine addiction, depressive and anxious states, composed by:a) a nucleus in the form of granules and tablets comprising an active principle dispersed in a particular cellulosic matrix; and optionally by:b) a filming protection of the nucleus.
Type:
Grant
Filed:
July 21, 1994
Date of Patent:
January 14, 1997
Assignee:
Laboratorio Farmaceutico C.T. S.r.l.
Inventors:
Ubaldo Conte, Aldo La Manna, Giuseppe Tessitore
Abstract: Thiadiazole derivatives of general formula (I) ##STR1## wherein R.sub.1 is selected from the class consisting of: C.sub.1 -C.sub.10 linear or branched alkyl, benzyl, optionally substituted at the aromatic ring with one or more groups selected on their turn from the class consisting of : C.sub.1 -C.sub.20 linear or branched alkyl residues , nitro groups, halogen atoms, C.sub.1 -C.sub.20 linear or branched alkoxy, hydroxy and C.sub.2 -C.sub.20 linear or branched acyloxy groups, R.sub.2 is selected from H, C.sub.2 -C.sub.10 alkanoyl, cycloalkanoyl wherein this ring has from 3 to 10 carbon atoms, aroyl, and R.sub.3 is selected from H and C.sub.1 -C.sub.10 alkyl, for the treatment of depressive states and anxiety, a process for their preparation and relative pharmaceutical compositions containing them as the active ingredient.
Type:
Grant
Filed:
July 9, 1993
Date of Patent:
March 28, 1995
Assignee:
Laboratorio Farmaceutico C.T. S.r.l.
Inventors:
Mario Brufani, Antonella Loche, Vincenzo Perlini, Donato Pocar
Abstract: The use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions useful for the release form ethyl alcohol consumption and the compostions obtained.
Type:
Grant
Filed:
June 2, 1989
Date of Patent:
January 8, 1991
Assignee:
Laboratorio Farmaceutico C.T. S.r.l.
Inventors:
Gian Luigi Gessa, Fabio Fadda, Chiara Mormile di Campochiaro
Abstract: Crystalline polymorphic forms of a compound of formula N-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide are described. The two polymorphic forms, named polymorphic Form A and polymorphic Form B, can be used in the treatment of drug addiction and alcoholism and have very good stability. Methods for preparing the polymorphic forms are also described.